Douglas V Faller
7PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 12, 2022
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin
|Nov 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin
|Nov 18, 2021
Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.Mikkael A Sekeres, Justin Watts, Atanas Radinoff
|Jun 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis.Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar
|Apr 30, 2021
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models.Fabien Muselli, Lucas Mourgues, Rita Morcos
|Jan 23, 2021
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.Mikkael A Sekeres, Justin Watts, Atanas Radinoff
Pageof 2
Frequent Collaborators
3 joint publications
Joshua F Zeidner
3 joint publications
Lwona Dobler
2 joint publications
Kyu-Pyo Kim
2 joint publications
Yasutoshi Kuboki
2 joint publications
Chia-Chi Lin
2 joint publications
Saran Vardhanabhuti
2 joint publications
Toshio Shimizu
2 joint publications
Maria Diez Campelo
2 joint publications
Patricia Font Lopez
2 joint publications
Mikkael A Sekeres
